These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 14651407)

  • 41. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
    Achakzai M; Kassi M; Kasi PM
    Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug sharing among heroin networks: implications for HIV and hepatitis B and C prevention.
    Koester S; Glanz J; Barón A
    AIDS Behav; 2005 Mar; 9(1):27-39. PubMed ID: 15812611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
    Devi KhS; Singh NB; Singh HL; Singh YM
    J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What do intravenous drug users think about hepatitis?].
    Grimnes G
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2164-6. PubMed ID: 16138126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis services at an injecting drug user outreach clinic.
    Moriarty H; Kemp R; Robinson G
    N Z Med J; 2001 Mar; 114(1128):105-6. PubMed ID: 11346154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Crofts N; Aitken CK; Kaldor JM
    Med J Aust; 1999 Mar; 170(5):220-1. PubMed ID: 10092920
    [No Abstract]   [Full Text] [Related]  

  • 47. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis B.
    Ramsay ME; Balogun MA; Teo CG; Mortimer PP
    BMJ; 2000 Feb; 320(7233):512; author reply 513. PubMed ID: 10678875
    [No Abstract]   [Full Text] [Related]  

  • 48. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High HIV testing and low HIV prevalence among injecting drug users attending the Sydney Medically Supervised Injecting Centre.
    Salmon AM; van Beek I; Amin J; Grulich A; Maher L
    Aust N Z J Public Health; 2009 Jun; 33(3):280-3. PubMed ID: 19630850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prisoners' attitudes toward Hepatitis B vaccination.
    Vallabhaneni S; Macalino GE; Reinert SE; Schwartzapfel B; Wolf FA; Rich JD
    Prev Med; 2004 Jun; 38(6):828-33. PubMed ID: 15193905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poor validity of self-reported hepatitis B virus infection and vaccination status among young drug users.
    Kuo I; Mudrick DW; Strathdee SA; Thomas DL; Sherman SG
    Clin Infect Dis; 2004 Feb; 38(4):587-90. PubMed ID: 14765355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
    Imani R; Karimi A; Rouzbahani R; Rouzbahani A
    East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of hepatitis C in intravenous opioid users presenting in the early phase of injecting drug use in Singapore.
    Winslow M; Subramaniam M; Ng WL; Lee A; Song G; Chan YH
    Singapore Med J; 2007 Jun; 48(6):504-8. PubMed ID: 17538746
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India.
    Jindal N; Arora U; Singh K
    Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Knowledge about hepatitis B and C among patients attending family medicine clinics in Karachi.
    Khuwaja AK; Qureshi R; Fatmi Z
    East Mediterr Health J; 2002 Nov; 8(6):787-93. PubMed ID: 15568456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Broadening discussions of "safe" in hepatitis C prevention: a close-up of swabbing in an analysis of video recordings of injecting practice.
    Treloar C; Laybutt B; Jauncey M; van Beek I; Lodge M; Malpas G; Carruthers S
    Int J Drug Policy; 2008 Feb; 19(1):59-65. PubMed ID: 18312820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?
    Judd A; Hickman M; Hope VD; Sutton AJ; Stimson GV; Ramsay ME; Gill ON; Parry JV
    J Viral Hepat; 2007 Aug; 14(8):584-91. PubMed ID: 17650293
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Difficult to motivate intravenous addicts for vaccination against hepatitis. The campaign in Blekinge was not successful: it reached only 10 percent of the group].
    Eitrem R
    Lakartidningen; 2003 Feb; 100(6):424-6. PubMed ID: 12607435
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.